Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection

Vaccine

Volumn 14, Issue 6, 1996, Pages 492-494

  Cilia, Gustavo ^a   Peña, Begoña ^b   Marimón, José M ^a   Pérez Trallero, Emilio ^a  

^a Hospital Nuestra Senora de Aranzazu   (Spain)

^b Centro de Salud Arambizcarra II   (Spain)

Author keywords

Antibody responses; MMR vaccine; Upper respiratory tract infection; Vaccine failure

Indexed keywords

IMMUNOGLOBULIN G; MEASLES MUMPS RUBELLA VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEASLES; MUMPS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RUBELLA; SEROCONVERSION; VACCINATION;

EID: 0342468953     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00234-R     Document Type: Article

References (13)

1. Atkinson, W.L. and Markowitz, L.E. Measles and measles vaccine. Sem. Ped. Infect. Dis. 1991, 2, 100-107
2. Miller, E. The new measles campaign. Immunisation should prevent an epidemic predicted by modelling. Br. Med. J. 1994, 309, 1102-1103
3. Gustafson, T.L., Lievens, A.W., Brunell, P.A., Moellenberg, R.G., Buttery, C.M.G. and Sehulster, L.M. Measles outbreak in a fully immunized secondary school population. N. Engl. J. Med. 1987, 316, 771-774
4. Chen, R.T., Goldbaum, G.M., Wassilak, S.G.F., Markowitz, L.E. and Orenstein, W.A. An explosive point-source measles outbreak in a highly vaccinated population: modes of transmission and risk factors for disease. Am. J. Epidemiol. 1989, 129, 173-182
5. Briss, P.A., Fehrs, L.J., Parker, R.A., Wright, P.F., Sannella, E.G., Hutcheson, R.H. and Schaffner, W. Sustained transmission of mumps in a highly vaccinated population: assesment of primary vaccine failure and waning vaccine-induced immunity. J. Infect. Dis. 1994, 169, 77-82
6. Hersch, B.S., Fine, P.E., Kent, W.K. et al. Mumps outbreak in a highly vaccinated population. J. Ped. 1991, 119, 187-193
7. Krober, M.S., Stracener, C.E. and Bass, J.W. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds. J. Am. Med. Assoc. 1991, 265, 2095-2096
8. Markowitz, L.E. and Katz, S.L. Measles vaccine. In: Vaccines, 2nd edition (Eds Plotkin, S.A. and Mortimer, E.A. Jr). WB Saunders Company, Philadelphia, Pennsylvania, USA, 1994, pp. 229-276
9. Dennehy, P.H., Saracen, C.L. and Peter, G. Seroconversion rates to combined Measles-Mumps-Rubella-Varicella vaccine of children with upper respiratory tract infection. Pediatrics 1994, 94, 514-516
10. Halsey, N.A., Boulos, R., Mode, F. et al. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. N. Engl. J. Med. 1985, 313, 544-549
11. Ndikuyeze, A., Munoz, A., Stewart, J. et al. Immunogenicity and safety of measles vaccine in ill African children. Int. J. Epidemiol. 1988, 17, 448-455
12. Atkinson, W., Markowitz, L., Baughman, A. et al. Serologic response to measles vaccination among ill children (abstract no. 422). 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, 11-14 October, 1992, Anaheim, CA, USA
13. Joklik, W.K. Interferons. In: Virology, 2nd edn (Eds Fields, B.N., Knipe, D.M., Chanock, M.D., Hirsch, M.S., Melnick, J.L., Monath, T.P. and Roizman, B.). Raven Press, New York, 1990, pp. 383-410